Australian Pancreatic Genome Initiative Lab

Publications

Returning individual research results for genome sequences of pancreatic cancer
Johns, A. L.
; Miller, D. K.
; Simpson, S. H.
; Gill, A. J.
; Kassahn, K. S.
; Humphris, J. L.
; Samra, J. S.
; Tucker, K.
; Andrews, L.
; Chang, D. K.
; Waddell, N.
; Pajic, M.
; Pearson, J. V.
; Grimmond, S. M.
; Biankin, A. V.
; Zeps, N.;
Genome Medicine 6(5):42, 2014
Defining the molecular pathology of pancreatic body and tail adenocarcinoma
Dreyer, S. B.; Jamieson, N. B.; Upstill-Goddard, R.; Bailey, P. J.; McKay, C. J.; Biankin, A. V.; Chang, D. K.
BRITISH JOURNAL OF SURGERY 105(2):e183-e191, 2018
Extraprostatic extension (EPE) of prostatic carcinoma: is its proximity to the surgical margin or Gleason score important?
Gupta, R.; O'Connell, R.; Haynes, A. M.; Stricker, P. D.; Barrett, W.; Turner, J. J.; Delprado, W.; Horvath, L. G.; Kench, J. G.;
BJU International 116(3):343-350, 2015
Integrated genomic characterization of pancreatic ductal adenocarcinoma
Cancer Genome Atlas Research Network.
CANCER CELL 32(2):185-203, 2017
Lost in translation: returning germline genetic results in genome-scale cancer research
Johns, A. L., McKay, S. H., Humphris, J. L., Pinese, M., Chantrill, L. A., Mead, R. S., Tucker, K., Andrews, L., Goodwin, A., Leonard, C., High, H. A., Nones, K., Patch, A. M., Merrett, N. D., Pavlakis, N., Kassahn, K. S., Samra, J. S., Miller, D. K., Chang, D. K., Pajic, M., Australian Pancreatic Cancer Genome, Initiative, Pearson, J. V., Grimmond, S. M., Waddell, N., Zeps, N., Gill, A. J., Biankin, A. V.
Genome Medicine 28(9):41, 2017
Parafibromin-deficient (HPT-JT type, CDC73 mutated) parathyroid tumors demonstrate distinctive morphologic features
Gill, A. J.; Lim, G.; Cheung, V. K. Y.; Andrici, J.; Perry-Keene, J. L.; Paik, J.; Sioson, L.; Clarkson, A.; Sheen, A.; Luxford, C.; Elston, M. S.; Meyer-Rochow, G. Y.; Nano, M. T.; Kruijff, S.; Engelsman, A. F.; Sywak, M.; Sidhu, S. B.; Delbridge, L. W.; Robinson, B. G.; Marsh, D. J.; Toon, C. W.; Chou, A.; Clifton-Bligh, R. J.
American Journal Of Surgical Pathology 43(1):35-46, 2019
Genetic counselling and personalised risk assessment in the Australian pancreatic cancer screening program
Dwarte, T.; McKay, S.; Johns, A.; Tucker, K.; Spigelman, A. D.; Williams, D.; Stoita, A.
Hereditary Cancer in Clinical Practice 17:30, 2019
MutY-Homolog (MYH) inhibition reduces pancreatic cancer cell growth and increases chemosensitivity
Sharbeen, G.; Youkhana, J.; Mawson, A.; McCarroll, J.; Nunez, A.; Biankin, A.; Johns, A.; Goldstein, D.; Phillips, P.
Oncotarget 8(6):9216-9229, 2017
Inflammatory myofibroblastic tumors of the female genital tract are under-recognized: A low threshold for ALK immunohistochemistry Is required
Pickett, J. L.; Chou, A.; Andrici, J. A.; Clarkson, A.; Sioson, L.; Sheen, A.; Reagh, J.; Najdawi, F.; Kim, Y.; Riley, D.; Maidens, J.; Nevell, D.; McIlroy, K.; Valmadre, S.; Gard, G.; Hogg, R.; Turchini, J.; Robertson, G.; Friedlander, M.; Gill, A. J.
American Journal Of Surgical Pathology 41(10):1433-1442, 2017
Whole-genome landscape of pancreatic neuroendocrine tumours
Scarpa, A.; Chang, D. K.; Nones, K.; Corbo, V.; Patch, A. M.; Bailey, P.; Lawlor, R. T.; Johns, A. L.; Miller, D. K.; Mafficini, A.; Rusev, B.; Scardoni, M.; Antonello, D.; Barbi, S.; Sikora, K. O.; Cingarlini, S.; Vicentini, C.; McKay, S.; Quinn, M. C.; Bruxner, T. J.; Christ, A. N.; Harliwong, I.; Idrisoglu, S.; McLean, S.; Nourse, C.; Nourbakhsh, E.; Wilson, P. J.; Anderson, M. J.; Fink, J. L.; Newell, F.; Waddell, N.; Holmes, O.; Kazakoff, S. H.; Leonard, C.; Wood, S.; Xu, Q.; Nagaraj, S. H.; Amato, E.; Dalai, I.; Bersani, S.; Cataldo, I.; Dei Tos, A. P.; Capelli, P.; Davi, M. V.; Landoni, L.; Malpaga, A.; Miotto, M.; Whitehall, V. L.; Leggett, B. A.; Harris, J. L.; Harris, J.; Jones, M. D.; Humphris, J.; Chantrill, L. A.; Chin, V.; Nagrial, A. M.; Pajic, M.; Scarlett, C. J.; Pinho, A.; Rooman, I.; Toon, C.; Wu, J.; Pinese, M.; Cowley, M.; Barbour, A.; Mawson, A.; Humphrey, E. S.; Colvin, E. K.; Chou, A.; Lovell, J. A.; Jamieson, N. B.; Duthie, F.; Gingras, M. C.; Fisher, W. E.; Dagg, R. A.; Lau, L. M.; Lee, M.; Pickett, H. A.; Reddel, R. R.; Samra, J. S.; Kench, J. G.; Merrett, N. D.; Epari, K.; Nguyen, N. Q.; Zeps, N.; Falconi, M.; Simbolo, M.; Butturini, G.; Van Buren, G.; Partelli, S.; Fassan, M.; Australian Pancreatic Cancer Genome, Initiative; Khanna, K. K.; Gill, A. J.; Wheeler, D. A.; Gibbs, R. A.; Musgrove, E. A.; Bassi, C.; Tortora, G.; Pederzoli, P., et al.
NATURE 543(7643):65-71, 2017
RAF1 rearrangements are common in pancreatic acinar cell carcinomas
Prall, O. W. J.; Nastevski, V.; Xu, H.; McEvoy, C. R. E.; Vissers, J. H. A.; Byrne, D. J.; Takano, E.; Yerneni, S.; Ellis, S.; Green, T.; Mitchell, C. A.; Murray, W. K.; Scott, C. L.; Grimmond, S. M.; Hofmann, O.; Papenfuss, A.; Kee, D.; Fellowes, A.; Brown, I. S.; Miller, G.; Kumarasinghe, M. P.; Perren, A.; Nahm, C. B.; Mittal, A.; Samra, J.; Ahadi, M.; Fox, S. B.; Chou, A.; Gill, A. J.
MODERN PATHOLOGY 33(9):1811-1821, 2020
Provenance and risk in transfer of biological materials
Nielsen, J.; Bubela, T.; Chalmers, D. R. C.; Johns, A.; Kahl, L.; Kamens, J.; Lawson, C.; Liddicoat, J.; McWhirter, R.; Monotti, A.; Scheibner, J.; Whitton, T.; Nicol, D.
PLOS BIOLOGY 16(8):e2006031, 2018
Expression of phosphorylated-mTOR during the development of prostate cancer
Sutherland, S. I.
; Pe Benito, R.
; Henshall, S. M.
; Horvath, L. G.
; Kench, J. G.;
PROSTATE 74(12):1231-9, 2014
Return of individual research results from genomic research: A systematic review of stakeholder perspectives
Vears, D. F.; Minion, J. T.; Roberts, S. J.; Cummings, J.; Machirori, M.; Blell, M.; Budin-Ljosne, I.; Cowley, L.; Dyke, S. O. M.; Gaff, C.; Green, R.; Hall, A.; Johns, A. L.; Knoppers, B. M.; Mulrine, S.; Patch, C.; Winkler, E.; Murtagh, M. J.
PLoS One 16(11):e0258646, 2021